188 related articles for article (PubMed ID: 19907173)
1. Treatment and prevention of experimental autoimmune myocarditis with CD28 superagonists.
Wang S; Liu J; Wang M; Zhang J; Wang Z
Cardiology; 2010; 115(2):107-13. PubMed ID: 19907173
[TBL] [Abstract][Full Text] [Related]
2. CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.
Beyersdorf N; Hanke T; Kerkau T; Hünig T
Autoimmun Rev; 2006 Jan; 5(1):40-5. PubMed ID: 16338210
[TBL] [Abstract][Full Text] [Related]
3. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
Beyersdorf N; Hanke T; Kerkau T; Hünig T
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv91-5. PubMed ID: 16239397
[TBL] [Abstract][Full Text] [Related]
4. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory effects of α-GalCer in a murine model of autoimmune myocarditis.
Liu W; Li S; Tian W; Li W; Zhang Z
Exp Mol Pathol; 2011 Oct; 91(2):636-42. PubMed ID: 21791205
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody.
Rodríguez-Palmero M; Franch A; Castell M; Pelegrí C; Pérez-Cano FJ; Kleinschnitz C; Stoll G; Hünig T; Castellote C
J Rheumatol; 2006 Jan; 33(1):110-8. PubMed ID: 16395758
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis.
Wei L; Wei-Min L; Cheng G; Bao-Guo Z
Autoimmunity; 2006 Jun; 39(4):289-98. PubMed ID: 16891217
[TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
Liu W; Li WM; Gao C; Sun NL
J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
[TBL] [Abstract][Full Text] [Related]
9. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
Tischner D; Weishaupt A; van den Brandt J; Müller N; Beyersdorf N; Ip CW; Toyka KV; Hünig T; Gold R; Kerkau T; Reichardt HM
Brain; 2006 Oct; 129(Pt 10):2635-47. PubMed ID: 16921176
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway.
Haga T; Suzuki J; Kosuge H; Ogawa M; Saiki H; Haraguchi G; Maejima Y; Isobe M; Uede T
J Mol Cell Cardiol; 2009 May; 46(5):719-27. PubMed ID: 19233196
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific tolerance induced by IL-10 gene modified immature dendritic cells in experimental autoimmune myocarditis in rats.
Li WM; Liu W; Gao C; Zhou BG; Yang SS; Wang Z; Zhang RH; Gan RT; Kong YH; Li Y
Chin Med J (Engl); 2006 Oct; 119(19):1646-52. PubMed ID: 17042978
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
13. The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis.
George J; Barshack I; Goldberg I; Keren P; Gazit A; Levitzki A; Keren G; Roth A
Exp Mol Pathol; 2004 Jun; 76(3):234-41. PubMed ID: 15126106
[TBL] [Abstract][Full Text] [Related]
14. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
[TBL] [Abstract][Full Text] [Related]
15. A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation.
Futamatsu H; Suzuki J; Koga N; Adachi S; Kosuge H; Maejima Y; Haga T; Hirao K; Horuk R; Isobe M
J Mol Cell Cardiol; 2006 Jun; 40(6):853-61. PubMed ID: 16698032
[TBL] [Abstract][Full Text] [Related]
16. [The enhancing effect of "Xuebijing injection" on lipopolysaccharide-induced apoptosis of regulatory T cells and mediation of polarization of helper T cells].
Dai XG; Yao YM; Ai YH; Yu Y
Zhonghua Shao Shang Za Zhi; 2009 Apr; 25(2):106-10. PubMed ID: 19799034
[TBL] [Abstract][Full Text] [Related]
17. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody.
Yuan HT; Liao YH; Wang Z; Dong JH; Cao LS; Wang ZH; Wang JP; Fu ML
Can J Physiol Pharmacol; 2003 Feb; 81(2):84-8. PubMed ID: 12710519
[TBL] [Abstract][Full Text] [Related]
18. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation.
Azuma RW; Suzuki J; Ogawa M; Futamatsu H; Koga N; Onai Y; Kosuge H; Isobe M
Cardiovasc Res; 2004 Dec; 64(3):412-20. PubMed ID: 15537494
[TBL] [Abstract][Full Text] [Related]
20. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat.
Pando R; Barshack I; Raz A; Luboshits G; Haklai R; Maysel-Auslender S; Kloog Y; Keren G; George J
Cardiovasc Pathol; 2010; 19(2):94-101. PubMed ID: 19144546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]